Docosahexaenoic acid intake decreases proliferation, increases apoptosis and decreases the invasive potential of the human breast carcinoma cell line MDA-MB-231

International Journal of Oncology

Volumn 36, Issue 3, 2010, Pages 737-742

  Blanckaert, Vincent ^a   Ulmann, Lionel ^a   Mimouni, Virginie ^a   Antol, Johann ^b   Brancquart, Lucile ^a   Chénais, Benoît ^a  

^a UNIVERSITÉ DE NANTES   (France)

^b UNIV LILLE   (France)

Author keywords

Apoptosis; Breast cancer; Carcinoma cell; Docosahexaenoic acid; Invasion; Polyunsaturated fatty acid

Indexed keywords

CASPASE 3; DOCOSAHEXAENOIC ACID;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG INHIBITION; HUMAN; HUMAN CELL; METASTASIS; PHENOTYPE; PRIORITY JOURNAL; BIOSYNTHESIS; BREAST NEOPLASMS; CELL CYCLE; CELL NUCLEUS; CELL SURVIVAL; DRUG EFFECTS; GENE EXPRESSION REGULATION; METABOLISM; TIME; TUMOR CELL LINE; TUMOR INVASION;

APOPTOSIS; BREAST NEOPLASMS; CASPASE 3; CELL CYCLE; CELL LINE, TUMOR; CELL NUCLEUS; CELL PROLIFERATION; CELL SURVIVAL; DOCOSAHEXAENOIC ACIDS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PHENOTYPE; TIME FACTORS;

EID: 77149145825     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000549     Document Type: Article

References (26)

1. Holmes M and Willett W: Does diet affect breast cancer risk? Breast Cancer Res 6: 170-178, 2004.
2. Blanckaert VD, Schelling ME, Elstad CA and Meadows GG: Differential growth factor production, secretion, and response by high and low metastatic variants of B16BL6 melanoma. Cancer Res 53: 4075-4081, 1993.
3. Greenwald P, Clifford CK and Milner JA: Diet and cancer prevention. Eur J Cancer 37: 948-965, 2001.
4. Molokhia E and Perkins A: Preventing cancer. Prim Care 35: 609-623, 2008.
5. Russo GL: Dietary n-6 and n-3 polyunsaturated fatty acids: From biochemistry to clinical implications in cardiovascular prevention. Biochem Pharmacol 77: 937-946, 2009.
6. Berquin IM, Edwards IJ and Chen YQ: Multi-targeted therapy of cancer by omega-3 fatty acids. Cancer Lett 269: 363-377, 2008.
7. Hwang D, Chanmugam P, Ryan D, Boudreau M, Windhauser M, Tulley R, Brooks E and Bray G: Does vegetable oil attenuate the beneficial effects of fish oil in reducing risk factors for cardiovascular disease? Am J Clin Nutr 66: 89-96, 1997.
8. Ward OP and Singh A: Omega-3/6 fatty acids: alternative sources of production. Process Biochem 40: 3627-3652, 2005.
9. Van Beelen VA, Spenkelink B, Mooibroek H, Sijtsma L, Bosch D, Rietjens IM and Alink GM: An n-3 PUFA-rich microalgal oil diet protects to a similar extent as a fish oil-rich diet against AOM-induced colonic aberrant crypt foci in F344 rats. Food Chem Toxicol 47: 316-320, 2009.
10. Kinlen L: Diet and breast cancer. Br Med Bull 47: 462-469, 1991.
11. Barascu A, Besson P, Le Floch O, Bougnoux P and Jourdan M-L: CDK1-cyclin B1 mediates the inhibition of proliferation induced by omega-3 fatty acids in MDA-MB-231 breast cancer cells. Int J Biochem Cell Biol 38: 196-208, 2006.
12. Chamras H, Ardashian A, Heber D and Glaspy JA: Fatty acid modulation of MCF-7 human breast cancer cell proliferation, apoptosis and differentiation. J Nutr Biochem 13: 711-716, 2002.
13. Miura Y, Takahara K, Murata Y, Utsumi K, Tada M and Takahata K: Docosahexaenoic acid induces apoptosis via the Bax-independent pathway in HL-60 cells. Biosci Biotechnol Biochem 68: 2415-2417, 2004.
14. Judé S, Roger S, Martel E, Besson P, Richard S, Bougnoux P, Champeroux P and Le Guennec J-Y: Dietary long-chain omega-3 fatty acids of marine origin: a comparison of their protective effects on coronary heart disease and breast cancers. Prog Biophys Mol Biol 90: 299-325, 2006.
15. Vibet S, Goupille C, Bougnoux P, Steghens J-P, Goré J and Mahéo K: Sensitization by docosahexaenoic acid (DHA) of breast cancer cells to anthracyclines through loss of glutathione peroxidase (GPx1) response. Free Radic Biol Med 44: 1483-1491, 2008.
16. Siddiqui RA, Harvey K and Stillwell W: Anticancer properties of oxidation products of docosahexaenoic acid. Chem Phys Lipids 153: 47-56, 2008.
17. Delsal J: Nouveau procédé d'extraction des lipides du sérum par le méthylal. Application aux micro-dosages du cholestérol total, des phosphoamino-lipides et des protéines. Bull Soc Chim Biol 26: 99-105, 1944.
18. Slover HT and Lanza E: Quantitative analysis of food fatty acids by capillary gas chromatography. J Am Oil Chem Soc 56: 933-943, 1979.
19. Winnicka K, Bielawski K, Bielawska A and Surazynski A: Antiproliferative activity of derivatives of ouabain, digoxin and proscillaridin A in human MCF-7 and MDA-MB-231 breast cancer cells. Biol Pharm Bull 31: 1131-1140, 2008.
20. Siddiqui R, Zerouga M, Wu M, Castillo A, Harvey K, Zaloga G and Stillwell W: Anticancer properties of propofoldocosahexaenoate and propofol- eicosapentaenoate on breast cancer cells. Breast Cancer Res 7: 645-654, 2005.
21. Ding W, Vaught J, Yamauchi H and Lind S: Differential sensitivity of cancer cells to docosahexaenoic acid-induced cytotoxicity: the potential importance of down-regulation of superoxide dismutase 1 expression. Mol Cancer Ther 3: 1109-1117, 2004.
22. Stoll B: Breast cancer and the Western diet: role of fatty acids and antioxidant vitamins. Eur J Cancer 34: 1852-1856, 1998.
23. Zerouga M, Jenski LJ, Booster S and Stillwell W: Can docosahexaenoic acid inhibit metastasis by decreasing deformability of the tumor cell plasma membrane? Cancer Lett 119: 163-168, 1997.
24. Seiki M: Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion. Cancer Lett 194: 1-11, 2003.
25. Stillwel lW, Shaikh S, Zerouga M, Siddiqui R and Wassall S: Docosahexaenoic acid affects cell signaling by altering lipid rafts. Reprod Nutr Dev 45: 559-579, 2005.
26. Biondo PD, Brindley DN, Sawyer MB and Field CJ: The potential for treatment with dietary long-chain polyunsaturated n-3 fatty acids during chemotherapy. J Nutr Biochem 19: 787-796, 2008.